Moderna Future Growth
Future criteria checks 0/6
Moderna's revenue and earnings are forecast to decline at 1% and 15.5% per annum respectively while EPS is expected to decline by 22.2% per annum.
Key information
-15.5%
Earnings growth rate
-22.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | -1.0% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 10 Mar 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 7,849 | -413 | -713 | -264 | 12 |
| 12/31/2024 | 6,696 | -1,154 | -886 | -837 | 18 |
| 12/31/2023 | 7,630 | -897 | -759 | -439 | 18 |
| 12/31/2022 | 19,263 | 8,362 | 4,581 | 4,981 | N/A |
| 9/30/2022 | 21,390 | 11,765 | 6,201 | 6,629 | N/A |
| 6/30/2022 | 22,995 | 14,055 | 9,215 | 9,653 | N/A |
| 3/31/2022 | 22,600 | 14,638 | 13,031 | 13,412 | N/A |
| 12/31/2021 | 18,471 | 12,202 | 13,336 | 13,620 | N/A |
| 9/30/2021 | 11,831 | 7,061 | 11,386 | 11,574 | N/A |
| 6/30/2021 | 7,019 | 3,495 | 9,083 | 9,191 | N/A |
| 3/31/2021 | 2,732 | 598 | 5,007 | 5,104 | N/A |
| 12/31/2020 | 803 | -747 | 1,959 | 2,027 | N/A |
| 9/30/2020 | 246 | -597 | 613 | 664 | N/A |
| 6/30/2020 | 106 | -488 | -374 | -336 | N/A |
| 3/31/2020 | 52 | -505 | -451 | -421 | N/A |
| 12/31/2019 | 60 | -514 | -491 | -459 | N/A |
| 9/30/2019 | 82 | -535 | -489 | -451 | N/A |
| 6/30/2019 | 106 | -499 | -482 | -424 | N/A |
| 3/31/2019 | 122 | -459 | -445 | -364 | N/A |
| 12/31/2018 | 135 | -402 | -437 | -331 | N/A |
| 9/30/2018 | 192 | -299 | -447 | -343 | N/A |
| 6/30/2018 | 192 | -280 | -412 | -305 | N/A |
| 3/31/2018 | 199 | -266 | -432 | -350 | N/A |
| 12/31/2017 | 206 | -270 | -390 | -331 | N/A |
| 12/31/2016 | 108 | -230 | 34 | 67 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0QF's earnings are forecast to decline over the next 3 years (-15.5% per year).
Earnings vs Market: 0QF's earnings are forecast to decline over the next 3 years (-15.5% per year).
High Growth Earnings: 0QF's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 0QF's revenue is expected to decline over the next 3 years (-1% per year).
High Growth Revenue: 0QF's revenue is forecast to decline over the next 3 years (-1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0QF's Return on Equity is forecast to be high in 3 years time